Tag: Immunogenicity
CEPI to provide US$3.6 million fund for self-amplifying mRNA vaccine technology...
Funding will support optimisation of Gennova Biopharmaceutical's technology platform to enhance immunogenicity
Bharat Biotech’s iNCOVACC, world’s first Intra Nasal vaccine, gets emergency use...
Heterologous booster dose studies were conducted for safety and immunogenicity in ~875 subjects at 9 trial sites across India
IVI & Bharat Biotech begin Chikungunya vaccine trials in Costa Rica
Phase II and III trials are funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with support from the Ind-CEPI mission of the Department of Biotechnology (DBT), India.............................
Single dose vaccine, Sputnik Light, authorized for use in Russia
The Sputnik Light vaccine elicits the development of virus neutralizing antibodies in 91.67% of individuals on the 28th day post immunization.......................
DCGI nod to Serum Institute for conducting human trials of Oxford...
The Drugs Controller General of India has given the Serum Institute of India a green light to conduct phase 2 and 3 human trials of the Oxford-AstraZeneca COVID-19 vaccine candidate in India..................
Bharat Biotech’s Chikunguniya vaccine enters Phase-1 clinical trials
The placebo-controlled study of the vaccine involves 60 healthy volunteers, mentioned the statement from the company.......